风湿免疫病患者中免疫球蛋白水平与年龄相关性分析
Analysis of the Correlation between Immunoglobulin Levels and Age in Patients with Rheumatic Immune Diseases
DOI: 10.12677/acm.2025.151026, PDF,   
作者: 朱广婷*, 刘 婷, 李 芳#:青岛大学附属泰安市中心医院风湿免疫科,山东 泰安;阚伟浩:青岛大学附属泰安市中心医院消化内科,山东 泰安
关键词: 免疫球蛋白年龄风湿免疫病Immunoglobulin Age Rheumatic Immune Diseases
摘要: 目的:旨在研究风湿免疫病患者不同年龄组间血清免疫球蛋白(IgG, IgA, IgM)的含量特点。方法:选取2023年1月至2023年12月就诊于泰安中心医院风湿免疫科门诊及住院患者的病历资料共13,949例。统计其IgM、IgG、IgA值进行相关性分析,结果:对于IgG,三个年龄组的平均值分别为9.406、12.211、12.436,表明IgG水平随年龄增长呈上升趋势(F = 735.069, P < 0.001)。对IgM的分析结果显示1~30岁组的平均值最高(1.164),而60岁以上组最低(1.034) (F = 16.113, P < 0.001),IgA的平均值在>60岁组及31~60岁组显著高于1~30岁组,分别为2.751、2.69和1.205 (F = 1097.913, P < 0.001),随着年龄衰老IgA水平升高。结论:免疫球蛋白水平与风湿免疫病患者的年龄老化之间存在着一定的关联性。
Abstract: Objective: To investigate the content of immunoglobulin (IgG, IgA, IgM) in serum of patients with rheumatic immune diseases in different age groups and between adult men and women. Methods: A total of 13,949 outpatients and inpatients in the Department of Rheumatology and Immunology of Tai’an Central Hospital, Qingdao University from January 2023 to December 2023 were enrolled. Results: For IgG, the mean values of the three age groups were 9.406, 12.211 and 12.436, respectively, indicating that the IgG level showed an upward trend with age (F = 735.069, P < 0.001). The results of IgM analysis showed that the average value of IgM was the highest in the 1~30 years old group (1.164), and the lowest in the group over 60 years old (1.034) (F = 16.113, P < 0.001).The average value of IgA in >the 60-year-old group and the 31~60 years old group was significantly higher than that in the 1~30 years old group, which were 2.751, 2.69 and 1.205 (F = 1097.913, P < 0.001), respectively, and the level of IgA increased with aging. Conclusion: There is a certain relationship between immunoglobulin level and age in patients with rheumatic immune diseases.
文章引用:朱广婷, 刘婷, 阚伟浩, 李芳. 风湿免疫病患者中免疫球蛋白水平与年龄相关性分析[J]. 临床医学进展, 2025, 15(1): 168-171. https://doi.org/10.12677/acm.2025.151026

参考文献

[1] 高永生, 黄维星, 时丽秀. 不同年龄组血清中免疫球蛋白IgG、IgA、IgM的含量特点[J]. 中国冶金工业医学杂志, 2012, 29(5): 497-498.
[2] 高燕鲁. 风湿免疫病诊断与治疗要点[M]. 长春: 吉林科学技术出版社, 2016.
[3] 张奉春. 风湿免疫性疾病: 我们需要了解什么[J]. 协和医学杂志, 2017, 8(4): 204-206.
[4] Wen, X. and Li, B. (2023) A Population-Based Study on Autoimmune Disease. The Lancet, No. 401, 1829-1831.
[5] Pabst, O. (2012) New Concepts in the Generation and Functions of IgA. Nature Reviews Immunology, 12, 821-832.
[6] 王亚黎, 刘健, 叶文芳, 阮丽萍, 万磊. 类风湿关节炎患者免疫球蛋白变化及相关因素分析[J]. 中国临床保健杂志, 2014(2): 116-118.
[7] Oenk, K.D. (1989) Growth and Differentiation of B Cells from Patients with Juvenile Rheumatoid Arthritis. Arthritis & Rheumatology, 32, 150.
[8] 郭小兵, 苟建军, 张贵星. 临床常用检验项目解析[M]. 郑州: 郑州大学出版社, 2008.
[9] 徐勇, 傅松维, 徐友红. 风湿三项指标和免疫球蛋白检测对RA患者诊断中的应用[J]. 放射免疫学杂志, 2011, 24(1): 84-85.
[10] 邹刚, 卫海荣. 类风湿性关节炎患者血清免疫球蛋白和补体水平的检测与分析[J]. 中原医刊, 2006(11): 82.
[11] 余学芳, 汪海静, 陆学丹. 活动期类风湿关节炎患者前白蛋白的变化及意义[J]. 中国临床保健杂志, 2012, 15(5): 458-459.
[12] 徐雯, 陶娟. 血清免疫球蛋白、补体水平与初诊类风湿性关节炎活动度的相关性[J]. 临床医药实践杂志, 2008, 17(10): 815-816.
[13] 宋良, 谢深维, 廖攀. 生物制剂在风湿免疫病治疗中的临床应用价值——评《协和风湿免疫病答疑》[J]. 中国实验方剂学杂志, 2024, 30(7): 103.
[14] 杨桂枝. 血浆净化治疗在风湿免疫性疾病中的应用[J]. 双足与保健, 2017, 26(7): 100-101.